Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring

NCT02625103 is registered in ClinicalTrials.gov with Anders Fink-Jensen, MD, DMSci as lead sponsor.

NCT NCT02625103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02625103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring
Lead sponsor
Anders Fink-Jensen, MD, DMSci
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2015
Completion date
February 29, 2016
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia